Effect of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure: A Network Meta-Analysis.

Guo, Wen-Qin; Li, Lang; Su, Qiang; Dai, Wei-Ran; Ye, Zi-Liang

Guo, Wen-Qin; Li, Lang; Su, Qiang; Dai, Wei-Ran; Ye, Zi-Liang.

Guo WQ; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Li L; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Electronic address: gxmu2015@163.com.
Su Q; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Dai WR; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Ye ZL; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Value Health ; 20(10): 1427-1430, 2017 12.

Article en En | MEDLINE | ID: mdl-29241903

Asunto(s)

Diabetes Mellitus Tipo 2/tratamiento farmacológico; Inhibidores de la Dipeptidil-Peptidasa IV/efectos adversos; Insuficiencia Cardíaca/epidemiología; Hipoglucemiantes/efectos adversos; Teorema de Bayes; Inhibidores de la Dipeptidil-Peptidasa IV/uso terapéutico; Insuficiencia Cardíaca/etiología; Hospitalización; Humanos; Hipoglucemiantes/uso terapéutico; Ensayos Clínicos Controlados Aleatorios como Asunto; Riesgo

Palabras clave

dipeptidyl peptidase-4 inhibitor; heart failure; network meta-analysis; type 2 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Insuficiencia Cardíaca / Hipoglucemiantes Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google